Furthermore, the non-canonical Wnt factor, Wnt5a, which can be found at high levels in the plasma of patients with CLL [10, 11], can induce activation of ERK1/2 in neoplastic cells [12]. Here, MAPK3 is linked to B-cell chronic lymphocytic leukemia.